Our study demonstrated that, similar to dermal fibroblasts, ciprofloxacin has antifibrotic effects on cultured SSc ILD lung fibroblasts, by upregulating Fli1 and MMP1 levels and downregulating collagen type I and CCN2 gene expression. The gene discussed is CCN2; the disease is interstitial lung disease.